glp-1 reimbursement news Navigating Changes to Medication Coverage GLP-1 Weight-Loss Coverage: LSAs vs.

The scale cannot tell you if your protein intake is too low

Over the past two decades, Innerbody Research has helped tens of millions of readers make more informed decisions about staying healthy and living healthier lifestyles

Patients with pre-existing gastrointestinal conditionsinflammatory bowel disease, irritable bowel syndrome, or previous bowel surgeryshould maintain closer monitoring and lower thresholds for seeking medical input, as these populations may experience more pronounced or complex digestive effects

Berberine may also slow intestinal motility, which can worsen nausea and bloating, two of the most common side effects reported with GLP-1 therapies

doi: 10.3390/MEDICINA58020224 72 ChaiSLiuFYangZYuSLiuZYangQet al

Katsi V et al